Neothetics and Evofem Biosciences announce merger agreement
Neothetics and Evofem Biosciences announced an agreement whereby Evofem Biosciences will merge with Neothetics in an all-stock transaction. Upon closing, Neothetics will be renamed Evofem Biosciences, and will be under the leadership of Evofem’ CEO, Saundra Pelletier. October 17, 2017